After state food and drug administrations cracked the whip on e-commerce companies like Snapdeal for selling prescription drugs online, the government's new panel is working closely on suggesting amendments on several critical pharma laws and is also framing provisions to avoid monopolistic trade practices.
CNBC-TV18's Priya Sheth reports the panel is expected to suggest amendments to critical pharma laws like the Drugs and Cosmetics Act, the Drugs Price Control Order and other cyber crime laws.
The panel that is chaired by Maharashtra FDA Commissioner Harshadeep Kamble will also frame guidelines against monopolistic trade practices.
The panel is expected to submit its final guidelines by December as the present guidelines has no provision for the technology-based sale of drugs.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
